Skip to content
DataLookout
Menu

NCT07891806

REM Sleep Disruption and Its Potential Uses in Depression Management

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Final Montgomery-Åsberg Depression Rating Scale (MADRS) Score
Timeframe: Baseline and final post-intervention assessment, within 40 days after completion of the intervention.

Arms and interventions

REM-Contingent Haptic StimulationExperimental

Participants used the study iPhone and Apple Watch applications for sleep monitoring and received REM-contingent vibrotactile stimulation during algorithm-identified probable REM sleep. Sleep stage was estimated in real time from wrist accelerometry and photoplethysmography. A morning Smart Alarm haptic function was also available, as in the Control arm.

Monitoring-Only ControlOther

Participants used the same study iPhone and Apple Watch applications for sleep monitoring but did not receive REM-contingent night-time haptic stimulation. The same morning Smart Alarm haptic function available to the Experimental arm was also available in this group.

Devices: REM-Contingent Smartwatch Haptic Stimulation, Smartwatch Sleep Monitoring and Smart Alarm

Sites

2 sites in 1 country